Inhibitors of hepatitis C virus polymerase: synthesis and biological characterization of unsymmetrical dialkyl-hydroxynaphthalenoyl-benzothiadiazines.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2009-03-26

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/jm8010965PMID 19226162
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis and SAR of novel 1,1-dialkyl-2(1H)-naphthalenones as potent HCV polymerase inhibitors.

  2008cited by this paper
• Review: Hepatitis C Protease and Polymerase Inhibitors in Development

  2008cited by this paper
• Pegylated IFN-α2b plus ribavirin for treatment-naive patients coinfected with HCV and HIV

  2008cited by this paper
• Activity of a Potent Hepatitis C Virus Polymerase Inhibitor in the Chimpanzee Model

  2007cited by this paper
• Changing trends in hepatitis C–related mortality in the United States, 1995‐2004

  2007cited by this paper
• Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States

  2007cited by this paper
• Pegylated interferon and ribavirin in re-treatment of responder-relapser HCV patients.

  2007cited by this paper
• Natural history of chronic hepatitis C virus infection.

  2007cited by this paper
• Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of unsymmetrical 1-hydroxy-4,4-dialkyl-3-oxo-3,4-dihydronaphthalene benzothiadiazine derivatives.

  2007cited by this paper
• Specifically targeted antiviral therapy for hepatitis C virus.

  2007cited by this paper
• Non-nucleoside inhibitors of the HCV NS5B polymerase: progress in the discovery and development of novel agents for the treatment of HCV infections.

  2007cited by this paper
• Treating viral hepatitis C: efficacy, side effects, and complications

  2006cited by this paper
• Results of combination treatment with pegylated interferon and ribavirin in cirrhotic patients with hepatitis C infection

  2006cited by this paper
• Robust hepatitis C virus infection in vitro.

  2005cited by this paper
• Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

  2005cited by this paper
• Adaptive Mutations Producing Efficient Replication of Genotype 1a Hepatitis C Virus RNA in Normal Huh7 Cells

  2004cited by this paper
• Non-nucleoside inhibitors of the HCV polymerase.

  2004cited by this paper
• Membrane Association of the RNA-Dependent RNA Polymerase Is Essential for Hepatitis C Virus RNA Replication

  2004cited by this paper
• Hepatitis C Infection: A Clinical Review

  2004cited by this paper
• An NS 3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus

  2003cited by this paper
• An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus

  2003cited by this paper
• Projecting future complications of chronic hepatitis C in the United States

  2003cited by this paper
• The Hepatitis C Virus RNA-Dependent RNA Polymerase Membrane Insertion Sequence Is a Transmembrane Segment

  2002cited by this paper
• Hepatitis C virus infection: 10 years after the discovery of the virus

  2001cited by this paper
• Biochemical and structural analysis of the NS5B RNA‐dependent RNA polymerase of the hepatitis C virus

  2000cited by this paper
• Treatment of Chronic Hepatitis C Virus Infection

  2000cited by this paper
• Clinical Significance of Hepatitis C Virus Genotypes

  2000cited by this paper
• Efficient initiation of HCV RNA replication in cell culture.

  2000cited by this paper
• Natural history of chronic hepatitis C

  2000cited by this paper
• Genome of Human Hepatitis C Virus (HCV): Gene Organization, Sequence Diversity, and Variation

  2000cited by this paper
• Public Health Effort Unwittingly Spread HCV

  1999cited by this paper
• Replication of Subgenomic Hepatitis C Virus Rnas in a Hepatoma Cell Line

  1999cited by this paper
• Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line.

  1999cited by this paper
• Biochemical and kinetic analyses of NS5B RNA-dependent RNA polymerase of the hepatitis C virus.

  1998cited by this paper
• Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity

  1997cited by this paper
• Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.

  1997cited by this paper
• The epidemiology of acute and chronic hepatitis C.

  1997cited by this paper
• Candidate targets for hepatitis C virus-specific antiviral therapy.

  1997cited by this paper
• AN ANALYSIS OF LIVER TRANSPLANT EXPERIENCE FROM 37 TRANSPLANT CENTERS AS REPORTED TO MEDICARE

  1993cited by this paper
• An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

  1990cited by this paper
• Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

  1989cited by this paper
• Long-term results and complications in renal transplant recipients. Observations in the second decade.

  1988cited by this paper
• Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds.

  1988cited by this paper
• The role of acute hepatitis type A, B, and non-A non-B in the development of chronic active liver disease.

  1980cited by this paper
• Acute non-A, non-B hepatitis--clinical, epidemiological and histological characteristics.

  1980cited by this paper
• The long-term course of non-A, non-B post-transfusion hepatitis.

  1980cited by this paper
• Epidemiology and clinical characteristics of acute hepatitis types A, B, and non-A non-B.

  1979cited by this paper
• Post-transfusion chronic liver disease.

  1976cited by this paper
• Long-incubation post-transfusion hepatitis without serological evidence of exposure to hepatitis-B virus.

  1974cited by this paper

• Synthesis of Acyclic α-Quaternary Chiral Nitriles via Ni-Catalyzed Asymmetric Markovnikov Hydrocyanation of 1,1-Disubstituted and Trisubstituted Alkenes.

  2026cites this paper
• Supramolecular Heteroleptic Copper(II) Carboxylates: Synthesis, Spectral Characterization, Crystal Structures, and Enzyme Inhibition Assay

  2018cites this paper
• Investigation of the co-metabolic transformation of 4-chlorostyrene into 4-chlorophenylacetic acid in Pseudomonas fluorescens ST

  2018cites this paper
• Characterization of Aldehyde Dehydrogenases Applying an Enzyme Assay with In Situ Formation of Phenylacetaldehydes

  2017cites this paper
• Design and Development of HCV NS5B Polymerase Inhibitors

  2017cites this paper
• Novel methods for the synthesis of 1,5,2-diazaphosphinines as potential inhibitors of HCV polymerase

  2017cites this paper
• Co-metabolic formation of substituted phenylacetic acids by styrene-degrading bacteria

  2015cites this paper
• HCV-targeted antivirals: current status and future challenges.

  2014cites this paper
• Structure–Activity Relationships in the Development of Allosteric Hepatitis C Virus RNA‐Dependent RNA Polymerase Inhibitors: Ten Years of Research

  2013cites this paper
• Antiviral Drug Discovery

  2013cites this paper
• An Assessment of the Use of Chimpanzees in Hepatitis C Research Past , Present and Future : 2 . Alternative Replacement Methods

  2011cites this paper
• Quinoxalin-2(1H)-one derivatives as inhibitors against hepatitis C virus.

  2011cites this paper
• Recent advances in drug discovery of benzothiadiazine and related analogs as HCV NS5B polymerase inhibitors.

  2011cites this paper
• Hepatitis C NS5B polymerase inhibitors: functional equivalents for the benzothiadiazine moiety.

  2011cites this paper
• Non-nucleoside inhibitors of hepatitis C virus polymerase: current progress and future challenges.

  2010cites this paper
• An Assessment of the Use of Chimpanzees in Hepatitis C Research Past, Present and Future: 2. Alternative Replacement Methods

  2010cites this paper
• Pharmacophore modeling and 3D QSAR combined with virtual screening to identify novel inhibitors of protein targets of infectious diseases

  2010cites this paper
• HCV NS5B polymerase inhibitors.

  2010cites this paper
• Chapter 20 Progress towards the Discovery and Development of Specifically Targeted Inhibitors of Hepatitis C Virus

  2009cites this paper
• Optimization of Thienopyrrole‐Based Finger‐Loop Inhibitors of the Hepatitis C Virus NS5B Polymerase

  2009cites this paper
• Synthesis and biological characterization of B-ring amino analogues of potent benzothiadiazine hepatitis C virus polymerase inhibitors.

  2009cites this paper